Itonis Pharmaceuticals Announces Emesyl® Website on New Nausea Relief Product
Posted 09:01:00 10/21/2014 by Admin
Laguna Hills, CA - October 21,2014 - InvestorsHub NewsWire - Itonis, Inc. (OTC PINKSHEETS: ITNS) is pleased to announce that it has launched its www.emesyl.com website in preparation for the release of its new Emesyl® homeopathic product for nausea relief, with a new and improved packaging design.
On September 12, 2014, after Itonis received the first batch of Emesyl® from its manufacturer and released a photograph showing the original Emesyl® packaging design, Itonis’ executive team immediately decided to modify the Emesyl® packaging to better convey the product message and to drive marketing and ultimate sales.
“We had an opportunity to interrupt the full completion of Emesyl® to improve the packaging in the long-run for marketing purposes and to achieve sales,” said Mark Cheung, Itonis’ CEO, “so we immediately instituted design changes that can be viewed at www.emesyl.com. While we acknowledge the delay, we believe that the immediate box modification was a necessity that minimized further expenses while gaining an improved packaging design that would better deliver retail marketing advantages.”
The Company is also pleased to share that, with the originally delivered Emesyl®, it has obtained letters of intent with distributors, and is negotiating the final distribution agreements. Please stay tuned for further distribution updates.
About Itonis Pharmaceuticals
Itonis Pharmaceuticals, a division of Itonis, Inc., is headed by Charles Hensley, Ph.D., and its mission is to create and market over-the-counter and prescription homeopathic products that better people's lives. Dr. Hensley is a pioneer in the development and marketing of safe and effective therapeutic nutraceutical and homeopathic preparations. He was a founder of the company that launched the Zicam® Cold Remedy, making the product a household name and forever changing the marketing and product placement paradigm for homeopathic drugs in the United States. Dr. Hensley and his team plan to use the same methodologies to revolutionize the treatment of several other common ailments and other chronic diseases.
About Itonis, Inc.
Located in Laguna Hills, California, and founded in 2005, Itonis Inc. has focused on transitioning itself in the past year from acquiring high growth, market niche entrepreneurial companies, to a market leader focused on the distribution of innovative products to the medical and pharmaceutical industry. Please visit www.itonisholdings.com.
Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.
Stock Quote - ITNS
Investor RelationsItonis Holdings Company is a trade name of Itonis Inc. (OTC:ITNS), a publicly traded company.
Contact our office at (949) 200-8887 or email us at firstname.lastname@example.org for more information.
Latest Quarterly Reporthttp://www.otcmarkets.com/financialReportViewer?symbol=ITNS&id=180805